Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Pieris Pharmaceuticals Inc. (PIRS)

  • Technical Exchange News
  • Dec. 16, 2024, 08:10 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Pieris Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Pieris Pharmaceuticals Inc. (PIRS)

  • Technical Exchange News
  • Dec. 16, 2024, 08:10 UTC
  • 59
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Pieris Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Pieris Pharmaceuticals Inc. (PIRS)

  • Technical Exchange News
  • Dec. 16, 2024, 08:10 UTC
  • 58
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Pieris Pharmaceuticals, Inc. - Common Stock. New value: Pieris Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Pieris Pharmaceuticals Inc. (PIRS)

  • Technical Exchange News
  • Dec. 16, 2024, 00:12 UTC
  • 55
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Pieris Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Pieris Pharmaceuticals Inc. (PIRS)

  • Technical Exchange News
  • Dec. 16, 2024, 00:12 UTC
  • 61
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Pieris Pharmaceuticals, Inc. - Common Stock. New value: Pieris Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Pieris Pharmaceuticals Inc. (PIRS)

  • Technical Exchange News
  • Dec. 16, 2024, 00:12 UTC
  • 58
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Pieris Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Qualigen Therapeutics Inc. (QLGN)

  • Technical Exchange News
  • Dec. 14, 2024, 02:52 UTC
  • 66
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text

Marinus Pharmaceuticals Inc (MRNS)

  • Technical Exchange News
  • Dec. 14, 2024, 02:52 UTC
  • 61
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Genetic Technologies Ltd (GENE)

  • Technical Exchange News
  • Dec. 14, 2024, 02:51 UTC
  • 59
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Bankrupt.

Comment Full text

Elevai Labs (ELAB)

  • Technical Exchange News
  • Dec. 14, 2024, 02:51 UTC
  • 60
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 455
  • 456
  • 457
  • 458
  • 459
  • Next

Search

News categories

  • Technical Exchange News(12517)
  • Event(6229)
  • SEC News(286741)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162351)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin